Table 6 ROC curve analysis for predicting osteoporosis or osteopenia in the lumbar spine

Total

 TC (mmol/l)

0.235

0.662 (0.598–0.725)

4.960

0.675

0.560

<0.001

 FFA (mmol/l)

0.280

0.671 (0.608–0.735)

0.527

0.513

0.767

<0.001

 IL-6 (pg/ml)

0.273

0.641 (0.576–0.706)

7.500

0.575

0.698

<0.001

 ApoA1 (g/l)

0.231

0.630 (0.565–0.696)

1.345

0.550

0.681

<0.001

 ApoA1/ApoB

0.054

0.502 (0.433–0.572)

1.462

0.675

0.379

0.948

 Joint Indicators–1

0.512

0.812 (0.762–0.862)

/

0.788

0.724

<0.001

 Joint Indicators–2

0.497

0.805 (0.754–0.856)

/

0.738

0.759

<0.001

 Joint Indicators–3

0.510

0.812 (0.762–0.862)

/

0.769

0.741

<0.001

Male

 TC (mmol/l)

0.261

0.667 (0.554–0.780)

5.785

0.382

0.879

0.007

 FFA (mmol/l)

0.317

0.683 (0.570–0.796)

0.512

0.559

0.758

0.003

 IL-6 (pg/ml)

0.329

0.678 (0.564–0.793)

8.750

0.647

0.682

0.004

ApoA1/ApoB

0.233

0.604 (0.491–0.717)

1.390

0.824

0.409

0.090

 Joint Indicators–1

0.536

0.811 (0.723–0.900)

/

0.794

0.742

<0.001

 Joint Indicators–2

0.536

0.812 (0.724–0.900)

/

0.794

0.742

<0.001

Female

 TC (mmol/l)

0.222

0.620 (0.532–0.707)

6.025

0.302

0.920

0.013

 FFA (mmol/l)

0.248

0.665 (0.577–0.753)

0.526

0.508

0.740

0.001

 IL-6 (pg/ml)

0.348

0.669 (0.587–0.750)

7.450

0.548

0.800

<0.001

 ApoA1 (g/l)

0.148

0.579 (0.486–0.673)

1.385

0.548

0.600

0.101

 ApoA1/ApoB

0.107

0.519 (0.424–0.614)

1.476

0.627

0.480

0.697

 Joint Indicators–1

0.478

0.805 (0.740–0.871)

/

0.738

0.740

<0.001

 Joint Indicators–2

0.451

0.792 (0.724–0.859)

/

0.651

0.800

<0.001

 Joint Indicators–3

0.473

0.811 (0.746–0.876)

/

0.873

0.600

<0.001